Immunotherapies for GBM: Tumor Vaccines by Linda Liau, M.D., Ph.D., M.B.A.

Immunotherapies for GBM: Tumor Vaccines was presented by Linda Liau, M.D., Ph.D., M.B.A. on December 15th, 2016 at the Neurosurgery Grand Rounds jointly provided by Swedish Medical Center and the Seattle Science Foundation.
www.seattlesciencefoundation.org
Seattle Science Foundation is a non-profit organization dedicated to the international collaboration among physicians, scientists, technologists, engineers and educators. The Foundation's training facilities and extensive internet connectivity have been designed to foster improvements in health care through professional medical education, training, creative dialogue and innovation.
NOTE: All archived recorded lectures are available for informational purposes only and are only eligible for self-claimed Category II credit. They are not intended to serve as, or be the basis of a medical opinion, diagnosis, prognosis, or treatment for any particular patient.

[@kristinwohlschlagel6622]

This was wonderful to see. Thank you so much! I am a Hospice nurse and I had been wondering what the latest information was for GBM patients. I am especially glad to learn about the difference in mid-point and tail-end outcomes ~~ very encouraging!

[@muralis9478]

What's been the quality of life for some of these survivors Dr. Liau? The example you gave of the patient who's perhaps into his 14th year of survival with a son who was little when he began treatment and now in high school. Perhaps you can give us a general feel on his QOL?

[@bobbaj1775]

Hello Murali I have been following this treatment for a couple of years now and I can mention that everything that I read finds the QOL for patents have been best described as NORMAL.. This people have no side effects from the treatments and are moving on with their daily lifes. Excuse - They do develop a rash at the injection site. As silly as that sounds thats it a small rash (redness).